BMY
Bristol-Myers Squibb Company
Company Overview
| Mkt Cap | $87.16B | Price | $46.07 |
| Volume | 21.48M | Change | +0.99% |
| P/E Ratio | -9.7 | Open | $45.47 |
| Revenue | $48.3B | Prev Close | $45.62 |
| Net Income | $-8.9B | 52W Range | $42.52 - $63.33 |
| Div Yield | 2.48% | Target | $52.68 |
| Overall | 70 | Value | 70 |
| Quality | -- | Technical | 70 |
No chart data available
Stock Overview
Updated DailyBristol-Myers Squibb Company (BMY) is a leading Healthcare company in the Drug Manufacturers - Major industry, currently trading at $46.07 with a market capitalization of $87.16 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows BMY with a volume of 21.48 million shares. The stock opened down 0.33% from yesterday's close of $45.62. Current analyst estimates project earnings of $6.36 per share for this year, with next year targeting $6.03.
BMY demonstrates strong technical indicators based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including PFE, MRK, LLY, NVS, SNY.
Key investment considerations for BMY include strong overall investment metrics. The company offers a dividend yield of 2.48% and analyst price targets suggest potential upside of 14.3%. The stock shows reasonable valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 04:41 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BMY | $46.07 | +1.0% | 21.48M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bristol-Myers Squibb Company Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW